COMMUNIQUÉS West-GlobeNewswire

Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call

21/02/2025 - 14:30

MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who [...]

Tempus and Stemline Therapeutics, Inc., A Subsidiary of the Menarini Group, Announce Collaboration to Implement Tempus Next, an AI-Enabled Care Pathway Intelligence Platform to Support Patients with Metastatic Breast Cancer

21/02/2025 - 14:30

Up to 50% of patients with ER+/HER2- mBC could develop ESR1 mutations as a result of prior exposure to endocrine therapy in the metastatic setting. Testing to identify these mutations can help clinicians support more [...]

Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025

21/02/2025 - 14:30

MIAMI, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]

Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration

21/02/2025 - 15:00

ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BIOX) ("Biostax" or "the Company"), a biopharmaceutical company focused on developing innovative immune restoration therapies, today announced its [...]

Ensho Therapeutics Announces Presentation of Data Highlighting NSHO-101 as a Once-Daily Oral Agent for the Potential Treatment of Inflammatory Bowel Disease at ECCO 2025

21/02/2025 - 15:00

MORRIS PLAINS, N.J., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Ensho Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with [...]

Amwell® makes grants to new employees under inducement plan

21/02/2025 - 15:22

BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16,737 shares of its [...]

Marius Pharmaceuticals Unveils New Corporate Website and Announces Longevity & Endocrinology Advisory Boards

21/02/2025 - 15:30

RALEIGH, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals , a biopharmaceutical company dedicated to redefining the treatment of testosterone deficiency, is excited to announce the launch of its new [...]

Correction: Aino Health year-end report January-December 2024

21/02/2025 - 15:34

Correction: The reason for the correction is that the previous mailing did not contain the attached report. This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish [...]

Ipsen S.A. publie ses comptes consolidés 2024

21/02/2025 - 15:42

Ipsen S.A. - Etats financiers consolidés 2024 Pièce jointe Ipsen_Comptes Consolidés 2024_FR

Ipsen S.A. publishes its 2024 consolidated financial statements

21/02/2025 - 15:42

Ipsen S.A. - 2024 Consolidated Financial Statements Attachment Ipsen_Consolidated financial statements 2024_EN

Singular Genomics Announces Closing of Acquisition by Deerfield Management

21/02/2025 - 15:56

SAN DIEGO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]

Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff

21/02/2025 - 15:59

ALK ( ALKB:DC / OMX: ALK B / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2025

21/02/2025 - 17:45

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

21/02/2025 - 18:35

TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, development, manufacturing, [...]

Dogecoin Cash, Inc. (OTC:CBDS) Announces Strategic Expansion of Crypto Holdings with Acquisition of 420 Million Dogecoin Cash ($DOG)

21/02/2025 - 20:39

Update on Preferred Dividend Mesquite, Feb. 21, 2025 (GLOBE NEWSWIRE) -- February 21, 2025 – Mesquite, NV – Dogecoin Cash, Inc., formerly, Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce the execution of a [...]

Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned

21/02/2025 - 21:28

600% higher market cap per team member when compared to industry average. Source: Mr. Damodaran at the Stern School of Business at NYU . Current ownership breakdown: Insiders 79%; Independent Board Members 1%; Lead [...]

Fortrea to Add Erin L. Russell to Board of Directors

21/02/2025 - 21:33

Fortrea and Starboard enter into Cooperation Agreement DURHAM, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that it will appoint [...]

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock

21/02/2025 - 22:05

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the [...]

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

21/02/2025 - 22:05

Monrovia, CA, Feb. 21, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ: EXOZ, formerly Invizyne Technologies) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, [...]